View Latest Medical and Pharma Bids and Tenders

Supply of Medicine and Medical / Surgical equipments : Elisa Test kit for detection of HIV P24 antigen\nand antibodies to HIV; HIV 2 and HIV vi sub\ntype „O‟ antigen\n1. Test kit should detect of HIV P24 antigen\nand antibodies to HIV-1 (groups M and O)\nand HIV-2 inhuman serum or plasma.\n2. Number of tests shall be performed =480\ntests per kit\n3. Sensitivity should be 100%\n4. Specificity should be more than 99%\n5. Residual shelf life at the time of delivery\nshould be minimum of 18 months\n6. Each test kit should include adequate\npositive and negative controls\n7. Shall give a color change once serum is\nadded to the reagents.\n8. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as these\nreagents are kept at 2-6C.\n9. Reagent brochure, labels and any other\ninformation provided should be in English\nlanguage.\n10. Reagent shall contain FDA certification\nand/or WHO certification/ EU Quality\ncertification /free sales certificate and\ncertificate of use in the country in country of\norigin/ end user evaluation certificate/ or free\nsales certificate in USA, UK, France, Germany,\nCanada, New Zealand or Australia with\nstandard quality certificates etc .

Supply of Medicine and Medical / Surgical equipments : HIV Ag/Ab Combo Reagent for Analyzer\nCMIA technology-based HIV Ag/Ab Combo\nassay for blood donor screening.\nThe reagent kit shall be compatible with\nAlinitys Analyzer. CMIA HIV Ag/Ab Combo 4th\ngeneration assay should use two step\nchemiluminescent microparticle enzyme\nimmunoassay (CMIA) used for the\nsimultaneous qualitative detection of human\nimmunodeficiency virus (HIV) p24 antigen and\nantibodies to HIV type 1 (HIV-1 group M and\ngroup O and/or type 2 (HIV-2) in human serum\nand plasma, including specimens collected\npostmortem (non-heart-beating) to be used on\nAlinity s system for blood donor screening\npurposes. Ready To Use cartridges for the\neasy of use and less manual intervention.\nEach cartridge should be able to perform 500\ntests.\nThe reagent kit must be FDA approved for\nblood donor screening of HIV and certificates\nshall be attached.\nThe reagent kit must be NMRA approved for\nblood donor screening of HIV for blood and\nplasma donors.\nAll certificates of NMRA mentioning donor\nscreening purpose must be submitted for HIV\nAg/Ab Combo reagents.\nThe CMIA technology-based HIV Ag/Ab Combo\nassay should include calibrator kits, control\nkits, release control kits and reaction vessels\nalong with the reagent kits. At the time of\ndelivery expiery time shall be minimum of 10\nmonths.\nPacking : 500 tests etc .

Supply of Medicine and Medical / Surgical equipments : Dried Recombinant Factor, VIII Fraction\n500IU vial\nDried Recombinant Factor VIII Fraction 500IU vial\nDried factor VIII Fraction BP (Dried Recombinant\nAntihaemophilic Fraction) 500IU vial\nOR\nRecombinant Coagulation Factor VIII Ph Eur.\n500IU vial\nOR\nRecombinant Antihemophilic Factor USP 500IU vial\nOR\nDried Recombinant Antihaemophilic Fraction IP\n500IU vial\nEach vial to contain 500IU of concentrated,\npurified and viruses inactivated 3rd or 4th\ngeneration recombinant dried factor VIII Fraction\nBP, Ph Eur, USP or IP.\nNote:\n1. The item should be stable at temperature 2oC –\n8oC.\n2. The product should have minimum 24 months\nshelf life at the time of delivery to MSD.\n3. Tenderer should submit detailed specifications\nof the product offered.\n4. The product should ensure, at least two steps\non virus inactivation as recommended by\nWHO/US.FDA\n5. The purification process should be specified by\nthe manufacturer.\n6. Each batch should be certified as free from HIV\nhepatitis and other viruses.\n7. Anti viral test methods used for screening for\nHIV and Hepatitis viruses should be declared by\nthe manufacturer. The test methods used should\nbe approved by WHO/US.FDA.\n8. Each vial to be supplied with suitable diluent.\n9. The product should be protected from light.\nPacking : 10 vials in a Pack etc .